Incident opioid drug use and adverse respiratory outcomes among older adults with COPD
- 13 July 2016
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 48 (3) , 683-693
Abstract
We evaluated risk of adverse respiratory outcomes associated with incident opioid use among older adults with chronic obstructive pulmonary diseases (COPD).This was a retrospective population-based cohort study using a validated algorithm applied to health administrative data to identify adults aged 66 years and older with COPD. Inverse probability of treatment weighting using the propensity score was used to estimate hazard ratios comparing adverse respiratory outcomes within 30 days of incident opioid use compared to controls.Incident opioid use was associated with significantly increased emergency room visits for COPD or pneumonia (HR 1.14, 95% CI 1.00–1.29; p=0.04), COPD or pneumonia-related mortality (HR 2.16, 95% CI 1.61–2.88; p<0.0001) and all-cause mortality (HR 1.76, 95% CI 1.57–1.98; p<0.0001), but significantly decreased outpatient exacerbations (HR 0.88, 95% CI 0.83–0.94; p=0.0002). Use of more potent opioid-only agents was associated with significantly increased outpatient exacerbations, emergency room visits and hospitalisations for COPD or pneumonia, and COPD or pneumonia-related and all-cause mortality.Incident opioid use, and in particular use of the generally more potent opioid-only agents, was associated with increased risk for adverse respiratory outcomes, including respiratory-related mortality, among older adults with COPD. Potential adverse respiratory outcomes should be considered when prescribing new opioids in this population.Keywords
Funding Information
- The Lung Association-Canadian Thoracic Society National Grant Review/Grant-In-Aid (n/a)
This publication has 38 references indexed in Scilit:
- The performance of different propensity score methods for estimating marginal hazard ratiosStatistics in Medicine, 2012
- The Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Diagnosis Codes for Identifying Patients Hospitalized for COPD ExacerbationsChest, 2012
- Once-Daily Opioids for Chronic Dyspnea: A Dose Increment and Pharmacovigilance StudyJournal of Pain and Symptom Management, 2011
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- PreBötzinger Complex Neurokinin-1 Receptor-Expressing Neurons Mediate Opioid-Induced Respiratory DepressionThe Journal of Neuroscience, 2011
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2010
- The State of Outcome Research: Are We on Target?New England Journal of Medicine, 1989
- Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease.Thorax, 1986
- Dihydrocodeine for breathlessness in "pink puffers".BMJ, 1983
- Effects of Dihydrocodeine, Alcohol, and Caffeine on Breathlessness and Exercise Tolerance in Patients with Chronic Obstructive Lung Disease and Normal Blood GasesNew England Journal of Medicine, 1981